Agent-specific Shadoo responses in transmissible encephalopathies

Kohtaro Miyazawa1, Laura Manuelidis

  • 1Yale University Medical School, 333 Cedar Street, New Haven, CT 06510, USA.

Insights

Shadoo (Sho) protein reductions in transmissible spongiform encephalopathies (TSE) are agent-specific and not essential for infection. Sho does not appear to protect against toxic prion protein effects.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
  • Host prion protein (PrP) is crucial for TSE pathogenesis.
  • Shadoo (Sho) protein is structurally similar to PrP and its role in TSEs is unknown.

Purpose of the Study:

  • To investigate Shadoo (Sho) protein changes in response to various TSE agents.
  • To determine if Sho is required for TSE infection or protects against PrP toxicity.

Main Methods:

  • Infection of standard mice and Tga20 mice (high PrP levels) with distinct TSE agents (sporadic CJD, Asiatic CJD, kuru, vCJD, 22L scrapie).
  • Analysis of Sho and PrP levels and regional neuropathology.
  • Infection of neural GT1 cells with TSE agents.

Main Results:

  • Sho reductions were specific to the TSE agent used.
  • Sho levels did not consistently correlate with PrP misfolding.
  • Sho was not essential for TSE infection in GT1 cells, which remained healthy despite abundant abnormal PrP.

Conclusions:

  • Sho reduction is an agent-specific TSE hallmark, not a universal response.
  • Sho is not required for TSE infection and does not protect against the toxic effects of misfolded PrP.